Position in LLY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$8,278,466
+$1,904,460 QoQ
Shares Held
6,902
-0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#1,367
of 4,621 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRANSCEND CAPITAL ADVISORS, LLC holds $69,576,548 across 11 Drug Manufacturers - General names. LLY ranks #3 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
262,453 | $33,725,210 | |
| 2 | JNJ |
Johnson & Johnson
|
43,125 | $10,952,456 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
6,902 | $8,278,466 | |
| 4 | ABBV |
AbbVie Inc.
|
29,656 | $7,462,635 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
55,185 | $3,179,759 | |
| 6 | AMGN |
Amgen Inc
|
4,077 | $1,476,363 | |
| 7 | NVS |
Novartis AG
|
8,348 | $1,308,298 | |
| 8 | AZN |
Astrazeneca PLC
|
6,659 | $1,262,679 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,278,466 | 6,902 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $6,374,006 | 6,930 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $9,976,255 | 9,283 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $8,527,288 | 11,176 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $8,386,963 | 10,759 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $14,897,764 | 18,038 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $13,382,620 | 17,335 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $14,651,675 | 16,538 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $15,328,988 | 16,931 | Shares | Sole | 2024-07-02 | |
| 2024-03-31 | $11,990,697 | 15,413 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $8,616,140 | 14,781 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $7,758,842 | 14,445 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $7,130,840 | 15,205 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $5,103,564 | 14,861 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $5,125,052 | 14,009 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $4,352,614 | 13,461 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $4,391,371 | 13,544 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $3,893,200 | 13,595 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $3,772,336 | 13,657 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $3,081,975 | 13,339 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $2,796,242 | 12,183 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,306,058 | 6,991 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,220,882 | 7,231 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||